Decitabine as a First-Line Treatment for Older Adults Newly Diagnosed with Acute Myeloid Leukemia

PURPOSE: Decitabine, a DNA hypomethylating agent, was recently approved for use in Korea for older adults with acute myeloid leukemia (AML) who are not candidates for standard chemotherapy. This study aimed to evaluate the role of decitabine as a first-line treatment for older adults with AML. MATER...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Hyunsung, Chung, Haerim, Lee, Jungyeon, Jang, Jieun, Kim, Yundeok, Kim, Soo Jeong, Kim, Jin Seok, Min, Yoo Hong, Cheong, June-Won
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Yonsei University College of Medicine 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5122650/
https://www.ncbi.nlm.nih.gov/pubmed/27873493
http://dx.doi.org/10.3349/ymj.2017.58.1.35

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5122650/
https://www.ncbi.nlm.nih.gov/pubmed/27873493
http://dx.doi.org/10.3349/ymj.2017.58.1.35

Ejemplares similares